CIK: 0001791468
申报总市值
US$2.5亿
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CGEM | Cullinan Therapeutics INC | 股票-其他 | 18.37% | — | — | |
| 2 | PLRX | Pliant Therapeutics INC | 股票-其他 | 18.30% | — | -1.27% | |
| 3 | RPTX | Repare Therapeutics INC | 股票-其他 | 15.73% | — | +1.13% | |
| 4 | ✓ | 股票-其他 | 10.51% | — | — | ||
| 5 | ORTXUSD | Orchard Therapeutics PLC | 股票-其他 | 5.89% | — | +38.24% | |
| 6 | ✓ | Oncorus INC | 股票-其他 | 4.94% | — | +5.47% | |
| 7 | KROS | Keros Therapeutics INC | 股票-其他 | 4.93% | — | -7.69% | |
| 8 | ✓ | Ikena Oncology INC | 股票-其他 | 4.61% | — | — | |
| 9 | LRMR | Larimar Therapeutics INC | 股票-其他 | 4.43% | — | — | |
| 10 | ✓ | Inozyme Pharma INC | 股票-其他 | 3.68% | — | -6.84% | |
| 11 | ✓ | Freeline Therapeutics Hldgs | 股票-其他 | 3.41% | — | +1.74% | |
| 12 | ✓ | Akouos INC | 股票-其他 | 2.38% | — | -1.48% | |
| 13 | ✓ | 股票-其他 | 1.43% | — | -19.80% | ||
| 14 | CRVS | Corvus Pharmaceuticals INC | 股票-其他 | 0.42% | — | +38.35% | |
| 15 | GTHXEUR | G1 Therapeutics INC | 股票-其他 | 0.24% | — | -19.35% | |
| 16 | ✓ | 股票-其他 | 0.21% | — | +29.01% | ||
| 17 | OVID | Ovid Therapeutics INC | 股票-其他 | 0.20% | — | -70.08% | |
| 18 | GBTUSD | Global Blood Therapeutics In | 股票-其他 | 0.12% | — | -64.95% | |
| 19 | ADVMCHF | Adverum Biotechnologies INC | 股票-其他 | 0.08% | — | -32.09% | |
| 20 | 2655787D | Blueprint Medicines CORP | 股票-其他 | 0.07% | — | -36.36% | |
| 21 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 0.05% | — | -33.33% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | PLRX | Pliant Therapeutics INC | +3.2% | -1.27% | 减仓 |
| 2 | ORTXUSD | Orchard Therapeutics PLC | +2.3% | +38.24% | 加仓 |
| 3 | ✓ | 0% | +29.01% | 加仓 | |
| 4 | CRVS | Corvus Pharmaceuticals INC | -0.1% | +38.35% | 加仓 |
| 5 | RARE | Ultragenyx Pharmaceutical In | -0.1% | -33.33% | 减仓 |
| 6 | GTHXEUR | G1 Therapeutics INC | -0.1% | -19.35% | 减仓 |
| 7 | 2655787D | Blueprint Medicines CORP | -0.1% | -36.36% | 减仓 |
| 8 | ADVMCHF | Adverum Biotechnologies INC | -0.1% | -32.09% | 减仓 |
| 9 | GBTUSD | Global Blood Therapeutics In | -0.2% | -64.95% | 减仓 |
| 10 | OVID | Ovid Therapeutics INC | -0.3% | -70.08% | 减仓 |
| 11 | ✓ | -0.6% | -19.80% | 减仓 | |
| 12 | ✓ | Inozyme Pharma INC | -2.1% | -6.84% | 减仓 |
| 13 | ✓ | Akouos INC | -2.5% | -1.48% | 减仓 |
| 14 | ✓ | Freeline Therapeutics Hldgs | -3.6% | +1.74% | 加仓 |
| 15 | KROS | Keros Therapeutics INC | -3.7% | -7.69% | 减仓 |
| 16 | LRMR | Larimar Therapeutics INC | -4.7% | — | 不变 |
| 17 | RPTX | Repare Therapeutics INC | -8.7% | +1.13% | 加仓 |
| 18 | ✓ | Oncorus INC | -10.4% | +5.47% | 加仓 |
| 19 | CGEM | Cullinan Therapeutics INC | — | NEW | 新建仓 |
| 20 | ✓ | — | NEW | 新建仓 | |
| 21 | ✓ | Ikena Oncology INC | — | NEW | 新建仓 |
| 22 | AMWL | American Well Corporation | — | EXIT | 清仓 |
| 23 | ✓ | — | EXIT | 清仓 | |
| 24 | XBI | Ss Spdr S&p Biotech ETF | — | EXIT | 清仓 |